This report was first published by Endpoints News. To see the original version, click here
The Centers for Medicare and Medicaid Services has delayed a key pilot program focused on Medicare coverage for obesity medications, after insurance plans indicated they wouldn’t participate at this time.
Abe Sutton, head of the Center for Medicare and Medicaid Innovation, told Endpoints News in an interview Thursday that health plans were hesitant to join the pilot, citing instability in the Medicare Part D market and unknown utilization of the drugs.
您已阅读17%（545字），剩余83%（2669字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。